PHAR
USDPharming Group N.V. ADS each representing 10 ordinary shares
即時價格
價格圖表
關鍵指標
市場指標
開盤
$11.050
最高
$11.140
最低
$11.050
交易量
0.00M
公司基本面
市值
767.1M
行業
生物科技
國家
Netherlands
交易統計
平均交易量
0.00M
交易所
NGM
貨幣
USD
52週範圍
相關新聞
Pharming Group reports first quarter 2025 financial results and provides business update
First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, reflecting
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated
